PRPH Stock Analysis: Buy, Sell, or Hold?
PRPH - ProPhase Labs, Inc. Common Stock (DE)
$0.36
-0.08 (-18.97%)
▼
5d:
-39.58%
30d:
+157.16%
90d:
-33.69%
WAIT
LOW Confidence
Last Updated: January 2, 2026
Earnings: Apr 01, 2026
Get Alerted When PRPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called PRPH this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PRPH is down 39.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PRPH is down 39.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PRPH is currently trading at $0.36, which is considered oversold relative to its 30-day fair value range of $0.40 to $0.50.
Technical Outlook: Technically, PRPH is showing sideways momentum. Immediate support is located at $0.08, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 19.0% recently.
Market Sentiment: PRPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.80 (+3705.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PRPH is showing sideways momentum. Immediate support is located at $0.08, while resistance sits at $1.15. Short-term momentum is weak, with the stock down 19.0% recently.
Market Sentiment: PRPH has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $13.80 (+3705.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.40 -
$0.50
Company Quality Score
56/100
(HOLD)
Volume Confirmation
LOW
Confidence Score
78.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (75/100)
- BEARISH: Low volume - lacks confirmation
- BEARISH: Downward momentum (-19.0%)
- BULLISH: Trading 3705.8% below Wall St target ($13.80)
- WARNING: Recommendation downgraded due to -39.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$0.40 -
$0.50
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.08
Resistance Level
$1.15
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
10.09
Wall Street Target
$13.80
(+3705.8%)
Revenue Growth (YoY)
-37.6%
Earnings Growth (YoY)
-95.2%
Last updated: February 03, 2026 5:45 AM ET
Data refreshes hourly during market hours. Next update: 6:45 AM
Data refreshes hourly during market hours. Next update: 6:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PRPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$666 | 49 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 57 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$265 | 51 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$125 | 60 BUY |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$257 | 55 HOLD |
